Literature DB >> 26278137

Association of BCSC-1 with human esophageal squamous cell carcinoma.

C L Zhao, W J Yu, Z Q Gao, W T Li, W Gao, W W Yang, W G Feng, J Y Ju.   

Abstract

Breast cancer suppressor candidate-1 (BCSC-1) is a newly identified candidate tumor suppressor gene. BCSC-1 shows decreased levels in a variety of cancer types. In this study, we investigated the association between BCSC-1 and human esophageal squamous cell carcinoma (ESCC). BCSC-1 expression was detected in ESCC and normal tissues adjacent to tumor tissues by Western blot analysis and real-time PCR  as well as immunohistochemistry of paraffin sections. The relationships between BCSC-1 expression and various clinicopathological characteristics were analyzed. Western blot analysis and real-time PCR showed that levels of BCSC-1 protein and mRNA expression in ESCC significantly decreased compared with those in adjacent normal tissues.  Immunohistochemistry exhibited marked reduction of BCSC-1 in 38 of 105 ESCC specimens. Moreover, downregulation of BCSC-1 was associated with the grade of tumor cellular differentiation (P<0.05). These findings indicate that BCSC-1 downregulation in ESCC is associated with carcinogenesis and may play important roles during the process of ESCC cancer development.

Entities:  

Keywords:  BCSC-1; ESCC; immunohistochemistry.

Year:  2015        PMID: 26278137     DOI: 10.4149/neo_2015_091

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  2 in total

1.  Induction of the mitochondria-mediated apoptosis in human esophageal cancer cells by DS2, a newly synthetic diterpenoid analog, is regulated by Bax and caused by generation of reactive oxygen species.

Authors:  Yong-Cheng Ma; Yu Ke; Xiaolin Zi; Fei Zhao; Lin Yuan; Ying-Li Zhu; Xia-Xia Fan; Ning-Min Zhao; Qiao-Yan Li; Yu-Hua Qin; Hong-Min Liu
Journal:  Oncotarget       Date:  2016-12-27

2.  Association of BCSC-1 and MMP-14 with human breast cancer.

Authors:  Dalin Di; Lei Chen; Yingying Guo; Lina Wang; Huidong Wang; Jiyu Ju
Journal:  Oncol Lett       Date:  2018-02-06       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.